Initial studies, where brown adipocytes were genetically ablated with a toxin driven by the UCP1 promoter [93], demonstrated for the first time the protective effect of BAT against obesity and T2D. The gene discussed is UCP1; the disease is obesity due to melanocortin 4 receptor deficiency.